Pulmonary Rehabilitation Program in Patients With Post-Tuberculosis Lung Disease
Immediate and Three-Month Effects of a Pulmonary Rehabilitation Program in Patients With Post-Tuberculosis Lung Disease: A Prospective Longitudinal Study
연구 개요
상태
상세 설명
Persistent impairment after successfully treated pulmonary tuberculosis is increasingly recognized as an important source of chronic respiratory morbidity. Patients may experience dyspnea, exercise intolerance, fatigue, impaired mobility, and reduced health-related quality of life. Preliminary retrospective data from 37 patients suggested that structured pulmonary rehabilitation may improve the 6-minute walk distance, Timed Up and Go performance, dyspnea, perceived exertion, quality of life, and selected inflammatory indices. However, retrospective allocation and the absence of a longer follow-up limit causal interpretation.
The present study is designed as a prospective, assessor-blinded, parallel-group randomized controlled trial. It will assess both the immediate response to an individualized rehabilitation program and the maintenance of benefit three months after the supervised program has ended. The intervention combines aerobic training, resistance training, breathing exercises, education, and individualized symptom-management strategies. The control group will receive usual post-tuberculosis medical care and general physical-activity advice without a structured supervised pulmonary rehabilitation program during the study period.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: MAGDALENA-RODICA TRAISTARU, Professor, PhD
- 전화번호: +40723766778
- 이메일: rodica.traistaru@umfcv.ro
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
• Age 18 years or older.
- Documented history of pulmonary tuberculosis with anti-tuberculosis treatment completed according to national standards.
- No clinical evidence of active or relapsed tuberculosis at enrollment; microbiological reassessment will be performed when clinically indicated.
- Persistent respiratory symptoms, exercise limitation, or functional impairment considered attributable to post-tuberculosis lung disease.
- Clinical stability for at least 4 weeks before randomization, with no acute respiratory infection or acute exacerbation requiring treatment change.
- Ability to walk independently, with or without a usual assistive device, and to perform the study assessments.
- Ability to understand the study procedures and provide written informed consent.
Exclusion Criteria:
• Suspected or confirmed active, recurrent, or drug-resistant tuberculosis requiring treatment or isolation.
- Acute respiratory infection or acute cardiopulmonary decompensation within 4 weeks before enrollment.
- Unstable angina, recent myocardial infarction, uncontrolled arrhythmia, decompensated heart failure, severe uncontrolled hypertension, or another contraindication to exercise testing/training.
- Severe neurological, musculoskeletal, or cognitive impairment that prevents safe participation or valid outcome assessment.
- Current participation in another structured pulmonary rehabilitation or supervised exercise program.
- Planned major surgery or another condition likely to prevent completion of the 20-week follow-up.
- Any condition judged by the investigator to make participation unsafe or to substantially interfere with interpretation of the outcomes.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Individualized Pulmonary Rehabilitation Plus Standard Care
Participants assigned to the experimental arm will receive an 8-week individualized pulmonary rehabilitation program in addition to standard post-tuberculosis medical care.
The program will include three supervised sessions per week, each lasting approximately 60 minutes, consisting of aerobic training, resistance exercises, breathing exercises, education, symptom-management strategies, and an individualized home exercise program.
Outcome assessments will be performed at baseline, immediately after the 8-week intervention, and three months after completion of the rehabilitation program.
|
The intervention consists of an 8-week individualized outpatient pulmonary rehabilitation program, delivered through three supervised sessions per week, with each session lasting approximately 60 minutes. Each session will include: 5-10 minutes of warm-up and mobility exercises; 20-30 minutes of individualized aerobic training, such as walking, treadmill exercise, or cycle ergometry; resistance exercises targeting the major upper- and lower-limb muscle groups; breathing exercises, including diaphragmatic breathing, pursed-lip breathing, and thoracic expansion exercises; airway-clearance techniques when clinically indicated; education regarding symptom monitoring, energy conservation, physical activity, treatment adherence, and healthy lifestyle; an individualized home exercise program on non-supervised days. Exercise intensity and progression will be individualized according to baseline functional capacity, symptoms, Borg CR10 score, heart rate, oxygen saturation, comorbidities, and
Standard Post-Tuberculosis Care
|
|
활성 비교기: Standard Post-Tuberculosis Care
Participants assigned to the control arm will receive standard post-tuberculosis medical care, including routine clinical follow-up, management of respiratory symptoms and comorbidities, and general recommendations regarding physical activity.
Participants in this arm will not receive a structured or supervised pulmonary rehabilitation program during the 20-week study period.
Outcome assessments will be performed at baseline, at Week 8, and at Week 20.
|
Standard Post-Tuberculosis Care
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change From Baseline in EUROHIS-QOL-8 Total Score
기간: Baseline, Week 8, and Week 20.
|
Generic quality of life will be assessed using the EUROHIS-QOL-8 questionnaire.
The questionnaire contains eight items scored from 1 to 5. The total score ranges from 8 to 40, with higher scores indicating better quality of life.
A positive change indicates improvement.
|
Baseline, Week 8, and Week 20.
|
|
Change From Baseline in St George's Respiratory Questionnaire Total Score at Week 20
기간: Baseline to Week 20, corresponding to three months after completion of the 8-week pulmonary rehabilitation program.
|
Respiratory health-related quality of life will be assessed using the St George's Respiratory Questionnaire (SGRQ).
The total score ranges from 0 to 100, with higher scores indicating greater impairment.
The outcome will be calculated as the Week 20 score minus the baseline score.
A negative change indicates an improvement in respiratory health-related quality of life.
|
Baseline to Week 20, corresponding to three months after completion of the 8-week pulmonary rehabilitation program.
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change From Baseline in Six-Minute Walk Distance
기간: Baseline, Week 8, and Week 20
|
Functional exercise capacity will be assessed using the 6-Minute Walk Test.
The total distance walked in six minutes will be recorded in meters.
A greater walking distance indicates better functional exercise capacity.
|
Baseline, Week 8, and Week 20
|
|
Change From Baseline in Timed Up and Go Test Performance
기간: Baseline, Week 8, and Week 20.
|
Functional mobility will be assessed using the Timed Up and Go test.
The time required for the participant to stand up from a chair, walk 3 meters, turn, return to the chair, and sit down will be recorded in seconds.
A shorter completion time indicates better functional mobility.
|
Baseline, Week 8, and Week 20.
|
|
Change From Baseline in Modified Medical Research Council Dyspnea Grade
기간: Baseline, Week 8, and Week 20.
|
Dyspnea during daily activities will be assessed using the modified Medical Research Council scale.
Scores range from 0 to 4, with higher scores indicating greater dyspnea-related functional limitation.
A reduction in score indicates improvement.
|
Baseline, Week 8, and Week 20.
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- UMFCV-PTLD-2026-001
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
결핵(TB)에 대한 임상 시험
-
Far Eastern Memorial Hospital알려지지 않은TB-DIH의 보호 효과 | TB-DIH는 약물로 인한 간 기능 이상을 의미합니다.대만
-
François SpertiniUniversity of Oxford완전한
-
Riverside University Health System Medical Center알려지지 않은
-
Liverpool School of Tropical MedicineLiverpool University Hospitals NHS Foundation Trust모병
-
University College, LondonLondon School of Hygiene and Tropical Medicine; Aurum Institute; Foundation for Innovative... 그리고 다른 협력자들아직 모집하지 않음결핵(TB)남아프리카, 파키스탄, 짐바브웨
-
Global Alliance for TB Drug Development완전한결핵 | 결핵, 폐 | 결핵, 다제내성 | 광범위 약제내성결핵 | 결핵, MDR | XDR-TB | XDR-TB 이전남아프리카, 러시아 연방, 그루지야, 몰도바 공화국
-
Assistance Publique - Hôpitaux de Paris완전한
-
The HIV Netherlands Australia Thailand Research...Radboud University Medical Center; Bhumibol Adulyadej Hospital; Klang Hospital; Bamrasnaradura... 그리고 다른 협력자들모병
-
Universidad Nacional de Caaguazu아직 모집하지 않음
-
Shanghai Pulmonary Hospital, Shanghai, China아직 모집하지 않음
Individualized Pulmonary Rehabilitation Program에 대한 임상 시험
-
Uskudar State Hospital아직 모집하지 않음폐 질환 | 폐 재활 | 원격 의료